Helping men with HIV in fishing communities reduce heavy drinking and stay on HIV meds
Reducing hazardous alcohol use and optimizing treatment as prevention among men living with HIV in risk environments
This project offers counseling plus a cash-management approach to help men with HIV in Lake Victoria fishing communities drink less and keep their HIV virus undetectable by improving medication use.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | San Diego State University NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project ID | NIH-11159678 on NIH RePORTER |
What this research studies
You would be part of a randomized trial testing Kisoboka, a program that combines motivational interviewing with behavioral-economics strategies and a structural 'reduce cash on hand' element to lower hazardous drinking. The trial will enroll about 716 men living with HIV in fishing communities and use a factorial design to see which components drive benefit. Alcohol use will be measured with surveys (AUDIT-C) and a blood biomarker (PEth), and HIV outcomes will include antiretroviral adherence and viral load. Study visits and follow-up will occur in the Lake Victoria fishing communities where the program is delivered.
Who could benefit from this research
Good fit: Ideal candidates are men living with HIV who drink heavily and live in fishing communities around Lake Victoria in Uganda.
Not a fit: People who are not men, who do not live in those fishing communities, or who do not have hazardous alcohol use are unlikely to benefit from this specific program.
Why it matters
Potential benefit: If successful, the program could reduce heavy drinking and improve HIV treatment adherence, helping more people reach and maintain undetectable viral loads.
How similar studies have performed: A prior pilot randomized trial of Kisoboka showed early reductions in self-reported drinking, lower PEth biomarker levels, and a protective effect on ART adherence through six months, but this larger factorial trial is needed to confirm which parts work best.
Where this research is happening
San Diego, United States
- San Diego State University — San Diego, United States (Active)
Researchers
- Principal investigator: Kiene, Susan Maria — San Diego State University
- Study coordinator: Kiene, Susan Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.